Tag: Moderna

• Wednesday, August 19th 2026 - 21:47 UTC

  A personalized mRNA therapy passes a phase 3 melanoma trial for the first time

  

  Pharmaceutical companies Merck, known as MSD outside the United States and Canada, and Moderna announced on Wednesday that their individualized neoantigen therapy, intismeran autogene, met its endpoints in a phase 3 trial in melanoma patients. It is the first positive result at that stage for an mRNA-based cancer treatment.

• Tuesday, November 15th 2022 - 19:30 UTC

  Moderna says updated vaccine available to Uruguay has stronger antibody response

  

  The Moderna laboratories Tuesday reported that their two bivalent Omicron-targeting new messenger RNA (mRNA) technology booster vaccines (mRNA-1273.214 and mRNA-1273.222) have a superior antibody response compared to a booster dose of the basic RNA vaccine.

• Saturday, August 27th 2022 - 09:30 UTC

  Moderna sues Pfizer/Biontech over Covid-19 vax patent

  

  US pharmaceutical company Moderna Friday sued Pfizer / BioNTech over patent ownership infringement regarding the COVID-19 RNA vaccine

• Monday, August 15th 2022 - 21:00 UTC

  Britain approves Moderna's “#bivalent” COVID-19 vaccine

  

  British health authorities Monday greenlighted the use of a Moderna COVID-19 vaccine with a new formula designed to fight old strains as well as new variations in what has been dubbed a “bivalent” approach and will be used primarily as a booster for people aged 50 and over starting in the fall.

• Saturday, July 9th 2022 - 09:55 UTC

  Moderna's pediatrics vax to become available in Argentina later this month

  

  Argentina's Health Minister Carla Vizzotti Friday announced her country was about to receive the first batch of 1,400,000 doses of Moderna's pediatric COVID-19 vaccine to be applied to children between six months and three years of age.

• Thursday, April 28th 2022 - 20:49 UTC

  Moderna files for FDA approval to pedratric covid-19 vax

  

  Drug developers Moderna Thursday filed for clearance from the US Food and Drug Administration (FDA) to extend the use of their COVID-19 vaccine to children aged 6 months to 5 years, it was announced.

• Friday, January 28th 2022 - 09:22 UTC

  Moderna starts testing HIV vaccine in humans

  

  The Moderna Laboratory has begun the so-called phase 1 trial stage of an HIV vaccine using messenger RNA technology in the United States, on 56 uninfected adults, both the biotech company and the International AIDS Vaccine Initiative (IAVI) announced Thursday.

• Tuesday, April 20th 2021 - 15:02 UTC

  Big Pharma companies gross 152bn dollars since the beginning of the pandemic

  

  Despite setbacks with patients dying or suffering from undesired side effects which led to the suspension of some vaccines in various countries, the market value of pharmaceutical companies continues to rise, having amassed 152 billion US dollars in profits since the beginning of the coronavirus pandemic, it was reported.

• Monday, March 1st 2021 - 08:34 UTC

  AstraZeneca sells 7,7% interest in Moderna for a billion US dollars

  

  AstraZeneca Plc has sold its 7.7% stake in Moderna Inc for more than a billion US dollars after the U.S. biotechnology company's shares soared on the back of its coronavirus vaccine breakthrough, The Times reported.

• Tuesday, February 23rd 2021 - 09:14 UTC

  Pfizer plans to deliver 13 million doses of Covid-19 vaccine per week to US

  

  Drug maker Pfizer announced it expects to deliver more than 13 million doses of its Covid-19 vaccine per week to the United States by the middle of March, more than doubling its shipments from early February, a top Pfizer executive said in prepared testimony ahead of a Tuesday congressional hearing.